Overview

U.S. IVF services Market is poised to value over USD 5.4 billion by 2027 end at a CAGR of over 6.6% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of U.S. IVF services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the U.S. IVF services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the U.S. IVF services Market:
• BOSTON IVF
• CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
• CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO
• FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
• FERTILITY CENTER OF SAN ANTONI
• HOUSTON FERTILITY CENTER
• NEW HOPE FERTILITY CENTER
• SERVY MASSEY FERTILITY INSTITUTE
• REPRODUCTIVE MEDICINE ASSOCIATES
• SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
(Note: The list of the major players will be updated with the latest market scenario and trends)

U.S. IVF services Market Segmentation:
By Cycle Type
• Fresh IVF Cycles (Non-Donor)
• Thawed IVF Cycles (Non-Donor)
• Donor Egg IVF Cycles

By End User
• Fertility Clinics
• Hospitals
• Surgical centers
• Clinical research institutes

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the U.S. IVF services Market By Cycle Type and By End User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— US
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. U.S. IVF services Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of U.S. IVF services Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. U.S. IVF services Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. U.S. IVF services Market, By Cycle Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Fresh IVF Cycles (Non-Donor)
  7.2. Thawed IVF Cycles (Non-Donor)
  7.3. Donor Egg IVF Cycles

8. U.S. IVF services Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Fertility Clinics
  8.2. Hospitals
  8.3. Surgical centers
  8.4. Clinical research institutes

9. Market Share Analysis and Competitive Landscape  
   9.1. US Landscape - Key Players, Revenue and Presence
   9.2. US Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   9.3. US Emerging Companies
   9.4. US - Market Share Analysis and Key Regional Players
   9.5. US Key Player - Growth Matrix

10. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   10.1. BOSTON IVF
         10.1.1. Company Overview
         10.1.2. Product Portfolio
         10.1.3. SWOT Analysis
         10.1.4. Financial Overview
         10.1.5. Strategic Overview
   10.2. CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
         10.2.1. Company Overview
         10.2.2. Product Portfolio
         10.2.3. SWOT Analysis
         10.2.4. Financial Overview
         10.2.5. Strategic Overview
   10.3. CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO
         10.3.1. Company Overview
         10.3.2. Product Portfolio
         10.3.3. SWOT Analysis
         10.3.4. Financial Overview
         10.3.5. Strategic Overview
   10.4. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
         10.4.1. Company Overview
         10.4.2. Product Portfolio
         10.4.3. SWOT Analysis
         10.4.4. Financial Overview
         10.4.5. Strategic Overview
   10.5. FERTILITY CENTER OF SAN ANTONI
         10.5.1. Company Overview
         10.5.2. Product Portfolio
         10.5.3. SWOT Analysis
         10.5.4. Financial Overview
         10.5.5. Strategic Overview          
   10.6. HOUSTON FERTILITY CENTER
         10.6.1. Company Overview
         10.6.2. Product Portfolio
         10.6.3. SWOT Analysis
         10.6.4. Financial Overview
         10.6.5. Strategic Overview      
   10.7. NEW HOPE FERTILITY CENTER
         10.7.1. Company Overview
         10.7.2. Product Portfolio
         10.7.3. SWOT Analysis
         10.7.4. Financial Overview
         10.7.5. Strategic Overview
   10.8. SERVY MASSEY FERTILITY INSTITUTE
         10.8.1. Company Overview
         10.8.2. Product Portfolio
         10.8.3. SWOT Analysis
         10.8.4. Financial Overview
         10.8.5. Strategic Overview
   10.9. REPRODUCTIVE MEDICINE ASSOCIATES
         10.9.1. Company Overview
         10.9.2. Product Portfolio
         10.9.3. SWOT Analysis
         10.9.4. Financial Overview
         10.9.5. Strategic Overview
   10.10.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
         10.10.1. Company Overview
         10.10.2. Product Portfolio
         10.10.3. SWOT Analysis
         10.10.4. Financial Overview
         10.10.5. Strategic Overview

11. Pre and Post COVID-19 Impact
   11.1. Positive influence on the healthcare industry
   11.2. The financial disruption of the manufacturing sector
   11.3. Impact of COVID-19 on emerging companies
   11.4. Significant mandates in the healthcare regulations initiated by administrations
   11.5. The overall economic slowdown of the developing and developed nations

12. FutureWise SME Key Takeaway Points for Client

Tables

Figures